CLINICAL_TRIALS
trial_result
· 2014-02-07
Clinical Trial Update: Open-Label Study of Oral Treprostinil in Digital Ulcers [Phase 2]
Summary
An open-label Phase 2 trial evaluating oral treprostinil for digital ulcers in systemic sclerosis was terminated, with results posted in February 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Systemic Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2014-02-07